Proceedings of the 5th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2022)

<Previous Article In Volume
Next Article In Volume>

Nulliparous Woman with Polycystic Ovary Syndrome: Case Report

Authors
Muhammad Rusda1, *, Riang Salbia Tambunan1
1Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Infertility, Medical Faculty, Universitas Sumatera Utara, Medan, Indonesia
*Corresponding author. Email: m.rusda@usu.ac.id
Corresponding Author
Muhammad Rusda
Available Online 31 March 2023.
DOI
10.2991/978-94-6463-120-3_20How to use a DOI?
Keywords
polycystic ovary syndrome (PCOS); anovulation; Modified Ferriman Gaallway score; Polycystic ovarian morphology
Abstract

Background: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by a combination of signs and symptoms of androgen excess (hirsutism, hyperandrogenemia) and ovarian dysfunction (oligo-ovulation, polycystic ovary morphology (PCOM)). In ASRM/ESHRE consensus in 2003, PCOS diagnosis was established by 2 out of 3 symptoms. Anovulatory infertility in polycystic ovary syndrome can be treated with clomiphene citrate and gonadotropins or laparoscopic ovarian surgery in clomiphene-resistant women.

Case Report: Mrs R, 30 years old, P0A0, came to Haji Adam Malik gynaecology polyclinic on Jun 6, 2022, at 09.30 with a chief complaint of irregular menstruation experienced five months ago. The patient had menstrual duration for 10–14 days with a total volume of 4–5 times changing sanitary napkins. On vaginal examination, menstrual blood was found, and on vaginal tussae examination, no abnormalities were found. After evaluating the Tanner stage, the development of pubic hair was found to be stage 4, breast stage 4, with a total Modified Ferriman Gallway Score was 5. On ultrasound examination, polycystic ovary syndrome (PCOS) was found. The patient was diagnosed with anovulation polycystic ovary syndrome (PCOS) and managed with lifestyle improvements.

Conclusion: A patient with polycystic ovary syndrome (PCOS) has been described based on ASRM/EHSRE criteria and treated with lifestyle modification as the primary treatment to improve hormonal and metabolic profiles, as the primary basis for PCOS management with obesity.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 5th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2022)
Series
Advances in Health Sciences Research
Publication Date
31 March 2023
ISBN
978-94-6463-120-3
ISSN
2468-5739
DOI
10.2991/978-94-6463-120-3_20How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Muhammad Rusda
AU  - Riang Salbia Tambunan
PY  - 2023
DA  - 2023/03/31
TI  - Nulliparous Woman with Polycystic Ovary Syndrome: Case Report
BT  - Proceedings of the 5th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2022)
PB  - Atlantis Press
SP  - 133
EP  - 139
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-120-3_20
DO  - 10.2991/978-94-6463-120-3_20
ID  - Rusda2023
ER  -